Essayer OR - Gratuit
Hugel launches botulinum toxin Letybo in Malaysia
BioSpectrum Asia
|BioSpectrum Asia Sep 2025
South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.
-
The company's Malaysian partner Venusys Medical Sdn Bhd introduced Letybo at the Aesthetic Medicine & Surgery Conference & Exhibition (AMSC), the largest medical aesthetics confer
Cette histoire est tirée de l'édition BioSpectrum Asia Sep 2025 de BioSpectrum Asia.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE BioSpectrum Asia
BioSpectrum Asia
Nona Biosciences appoints Dr Josh Xiao as CSO
Nona Biosciences, a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, has announced the appointment of Dr Josh Xiao as Chief Scientific Officer (CSO). Dr Xiao will be based in both the US and China and report directly to Dr Di Hong, Chief Executive Officer of Nona Biosciences.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Korea lays focus on stabilising medical product supply
The Ministry of Health and Welfare (MoHW), South Korea government, recently held its 7th meeting with healthcare and pharmaceutical associations, bringing together the Ministry of Trade, Industry and Resources (MOTIR), and the Ministry of Food and Drug Safety (MFDS).
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Formosa Pharma partners with SERI to advance novel ophthalmic formulations for corneal diseases
Taiwan-based Formosa Pharmaceuticals, Inc. and the Singapore Eye Research Institute (SERI) have announced a strategic research collaboration to develop next-generation ophthalmic formulations.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Academy of Digital Health Sciences launches two new courses in AI
Academy of Digital Health Sciences (ADHS), based in India, has announced the launch of its landmark 'AI for All' Mission, a bold, mission-driven programme designed to democratise artificial intelligence (AI) across global healthcare systems.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
AstraZeneca Korea names Ohad Goldberg as new Country President
AstraZeneca Korea has appointed Ohad Goldberg, former President of AstraZeneca Israel, as its new Country President, effective May 1.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Holista executes binding JV for collagen facility in Australia
Holista Colltech has entered into a binding Joint Venture (JV) agreement with Swang Chai Chuan (SCC) for the funding, development and operation of an ovine nano-collagen production facility in Collie, Western Australia.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Medit establishes global orthodontic business division
Medit Corp., a global leader in digital dentistry solutions, has announced the establishment of its Global Orthodontic Business Division and the acquisition of Progressive Orthodontics, a leading orthodontic education institution headquartered in Aliso Viejo, California, through its US subsidiary, Medit USA Inc.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
GSK enters exclusive collaboration with SBP Group to accelerate hepatitis B treatment in China
GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsidiary Chia Tai Tianqing Pharmaceutical Group (CTTQ), to accelerate bepirovirsen in mainland China at launch.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
Singapore and China ink MoU for enhancing regulatory collaboration on health products
Singapore's Health Sciences Authority (HSA) and China's National Medical Products Administration (NMPA) have signed a Memorandum of Understanding (MoU) to renew their commitment in health products regulatory collaboration, so as to support faster access to new & innovative health products for patients & healthcare systems in both countries.
1 min
BioSpectrum Asia June 2026
BioSpectrum Asia
WHO BOOSTS TRIALS TARGETING $144B BY 2030
Since May 2025, the World Health Organization (WHO) has intensified efforts to strengthen global clinical trial ecosystems in response to rising demand for high-quality, equitable, and efficient research systems.
2 mins
BioSpectrum Asia June 2026
Listen
Translate
Change font size